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Abstract: The Second Annual Meeting of the European Virus Bioinformatics Center (EVBC), held
in Utrecht, Netherlands, focused on computational approaches in virology, with topics including
(but not limited to) virus discovery, diagnostics, (meta-)genomics, modeling, epidemiology, molecular
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structure, evolution, and viral ecology. The goals of the Second Annual Meeting were threefold: (i) to
bring together virologists and bioinformaticians from across the academic, industrial, professional,
and training sectors to share best practice; (ii) to provide a meaningful and interactive scientific
environment to promote discussion and collaboration between students, postdoctoral fellows, and
both new and established investigators; (iii) to inspire and suggest new research directions and
questions. Approximately 120 researchers from around the world attended the Second Annual
Meeting of the EVBC this year, including 15 renowned international speakers. This report presents
an overview of new developments and novel research findings that emerged during the meeting.
Keywords: bioinformatics; virology; viruses; software
1. Introduction
Bringing together the expertise of bioinformaticians and virologists is crucial, because often
fundamental computational issues need to be discussed that emerge from specific questions arising in
virus research. The issues are further accentuated by the fact that the era of big data has also reached
virology, in full strength. The European Virus Bioinformatics Center (EVBC) aims at reinforcing the
synergy between bioinformatics and virology at all levels, including national and international funding
scales, which is an urgent issue [1,2]. Collaboration between virologists and bioinformaticians is
necessary to establish improvements with respect to the adaptation of analytical tools to particular
requirements in virology, the development of cloud-based systems, the general assessment of
computational resources, and the understanding of how data can be shared efficiently. New diagnostic
tools and training in bioinformatics for virologists are also in high demand. Establishing these
improvements requires concerted efforts, across country borders. The Second Annual Meeting of the
EVBC was held at Utrecht University, Netherlands on 9–10 April 2018, in response to these issues, and
to discuss new advances and solutions. The Second Annual Meeting followed up on the successful first
meeting of the EVBC in Jena on 6–8 March 2017, so as to preserve the current momentum and point
out that the EVBC intends to establish a series of meetings to be held on a regular basis. The Scientific
Committee places high expectations on the excellence of the scientific program, which includes invited
lectures from renowned scientists whose work has been an inspiration for researchers in virology
and bioinformatics. The meeting allowed many interactions to take place between young and senior
scientists from academia as well as from the private sector. Over the two days, the meeting was
characterized by presentations to broadly cover topics from the field of virus bioinformatics. These
presentations are summarized in this report. The invited speakers presented very interesting talks and
stimulated interactive discussions that continued during coffee breaks and the ample poster sessions.
2. Selected Invited Lectures
A number of presentations were given by leading virologists and bioinformaticians; highlights
included the following:
2.1. Eugene Koonin Presented a Keynote Lecture on the Expansion of the Virus World in the Era
of Metaviromics
Metagenomics is changing the existing ideas on biodiversity and on the diversity and scope of the
earth’s virome in particular. Already at this time, the number of new viruses that are being discovered
by metagenomic approaches (metaviromics, for short) by far exceeds that identified by traditional
approaches. Accordingly, the International Committee on Taxonomy of Viruses (ICTV) has adopted new
rules that allow new virus species and higher taxa to be formally recognized on the basis of metagenomic
sequence alone, provided that the respective genome(s) is (are) (nearly) complete and that adequate
genome analysis is presented [3]. Metaviromics has led to the discovery of major new groups of viruses,
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the existence of which has not even been suspected previously. A striking example is the identification
of an expansive family of bacteriophages that are associated with bacteria of the phylum Bacteroidetes
and include crAssphage, the most abundant virus in the human virome [4,5]. Other discoveries in the
same vein include the identification of the first family of viruses infecting Marine Group II archaea, a
major group of uncultivated microbes [6], and a new group of giant viruses, Klosneuviruses, that encode
a far larger repertoire of translation system components than any previous known viruses [7]. This latter
finding is an illustration of the potential of metaviromics to uncover new biology, above and beyond the
expansion of the virome diversity. Metaviromics is also changing the existing ideas on the evolution of
viruses, in particular, by showing that the horizontal transfer of viruses between diverse hosts is far more
common than previously thought and, to a large extent, shapes the evolution of the virus world [8].
It should be emphasized that, to take the full advantage of the rapid proliferation of metagenomic
data, it is essential to apply the full armory of the most powerful and robust methods for
protein-sequence and -structure analysis. In the years to come, metaviromics can be expected to
advance at an accelerating rate and, combined with strategic choice of virus models for experimental
study, will be the foundation of the new virology. One of the expected outcomes of the advances of
metaviromics is a complete overhaul of virus taxonomy.
2.2. Anne Kupczok Talked about the Contribution of Mutation and Recombination to Dairy Phage Genome
Evolution over Three Decades
Virus evolution is driven not only by the inheritance of genetic modification but also by the
acquisition of foreign DNA. The evolutionary processes that affect genomic diversity include point
mutation, recombination, and gene turnover. The temporal dynamics of these molecular events
are crucial for our understanding of virus genome evolution. Heterochronous sequences, that is,
sequences from isolates that were sampled at different time points, can provide detailed evidence for
the evolutionary processes that shaped the populations over the sampling time. Evolutionary rates
have been estimated for bacteria and for eukaryotic viruses but only rarely for bacteriophages. Phages
are recognized as major contributors to bacterial evolution and ecology in nature. Thus, the estimation
of phage evolutionary rates provides the basis for a quantitative assessment of phage evolutionary
rates that are in action during phage bacteria antagonistic coevolution.
We recently estimated evolutionary rates from heterochronous dsDNA phage genomes [9]; 34
isolates of the 936 group of Siphoviridae phages were isolated using a Lactococcus lactis strain from
a single dairy over 29 years. The analysis pipeline used was based on publicly available tools that
were combined with the assessment of temporal signals at all stages of the analysis. Furthermore,
it was necessary to disentangle vertical and horizontal evolutionary processes to detect a separate
molecular clock signal in substitutions originating from mutational processes and in recombination
events. Using this approach, we estimated substitution and recombination rates individually. The
substitution rate of 1.9 × 10−4 substitutions per site per year estimated for lactococcal phages is
within the range of estimates for eukaryotic dsDNA viruses (∼10−5) and eukaryotic RNA viruses
(∼10−3) [10]. The reconstruction of recombination events revealed a rate of five recombination events
per year and 4.5 × 10−3 nucleotide alterations due to recombination per site per year. Thus, the
recombination rate exceeded the substitution rate, resulting in a relative effect of recombination to
mutation (r/m) of ∼24, which was homogenous over time. The analysis of bacterial genome-wide
data resulted in generally low r/m values, for example, 0.283 in Staphylococcus aureus [11] and 7.2 for
a Streptococcus pneumoniae lineage isolated over 20 years [12]. Thus, on the basis of our estimate of
r/m for a distinct Siphoviridae phage lineage, we conclude that the effect of recombination relative to
mutation can be elevated in phage genome evolution in comparison to bacteria. Frequent gene loss
and regain due to recombination with phages of the 936 group resulted in no detectable temporal
signal in gene content variation. Variable protein families were enriched in the early transcriptional
region that typically encodes non-essential proteins involved in phage–host interaction. The observed
recombination events are best explained by host coinfection by related, yet genetically different, phages.
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The genetic connectivity within the pangenome indicates that different phages of the 936 group share
an environment in which frequent coinfection events occur. Hence, different phage types can propagate
and evolve in an undefined starter culture that comprises diverse host strains.
The analysis of heterochronous sequencing data requires appropriate mathematical models and
bioinformatic tools. Models and tools for substitution rate estimation from heterochronous data are
well established (e.g., [13]). It is advised that recombination is detected and recombinant lineages
or sites are excluded before the substitution rate analysis [14]. Various methods and approaches are
available for this task (e.g., [11,15]), and none of these methods have been designed for heterochronous
data. Recent methodological developments for the inference of the bacterial recombination graph
in the BEAST2 framework [16] are promising also for the inference of recombination in phages and
viruses. To conclude, further development of mathematical models and bioinformatic tools for the
joint estimation of substitution, recombination, and gene turnover rates from heterochronous data is
necessary to provide an integrated framework for evolutionary rate estimation. These computational
methods will enhance our understanding of the temporal dynamics of these processes and of virus
genome evolution in general.
2.3. David Robertson Shared His Experience of Studying Virus–Host Interaction Networks and Modeling Viral
Control of the Host System
David presented his research group and collaborator’s work on virus–host molecular interaction
networks. Here, the focus was on the intracellular ”living” aspect of the virus, the exploitation of the
host system. This directed the study of viruses on both their own and their host’s genome/proteome and
the combined molecular interactions involved in the intracellular dynamics of infection. Most research
in this area has been on HIV-1, as it is for this system that the majority of experimental work exists. This
data was first painstakingly captured from the literature and visualized 10 years ago [17]. In particular,
it has been found that viruses tend to target highly connected proteins, that is, hubs, in the host because
of a combination of these being evolutionarily older molecules and thus more functionally ”central”,
because they are more efficient for optimal control of the cell, and because of the over-representation
of hubs in the main functions exploited by HIV-1 [18,19]. While these bipartite networks have been
useful for representing viral infection, they are essentially a static representation of a dynamic system.
Our aim has been to introduce a dynamic perspective by focusing on directed interactions in signaling
networks. Logical models, networks that use logical boolean formalism to represent interactions, are
one way of considering the directed interactions and permit in silico knockout experiments [20]. This
approach enables the virus interactions to be explicitly linked to their downstream effect.
In more recent work, we have applied control theory to the virus–host interaction network [21].
A system is controllable if with a suitable choice of inputs we can ”drive” the network to a required state.
The aim is to identify the driver nodes, the set of molecules that can control the network. Two states of
a large signaling network were compared: uninfected/normal and infected with HIV-1. The driver
nodes and a subset of critical driver nodes in the directed signaling network were identified before
and after infection. Interestingly, the critical driver nodes had a tendency to be targeted by the virus,
highlighting the way in which HIV-1 interacts with a complex ”moving” system. This emphasizes how
a virus takes control over the infected cell in a highly orchestrated manner. Our model indicates that a
virus fundamentally changes the controllability of the host system and uses an existing intracellular
network to control the cell; that is, a virus drives the network by targeting existing critical driver
nodes. As these are often hubs in the host network, this explains their over-representation in the set of
molecules targeted by HIV-1. Control theory thus gives a more nuanced understanding of infection
than previous approaches limited to static single-state networks.
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2.4. Arno Andeweg Took Delegates through Probing the Host Response to Viral Infection Using
Omics Approaches
To support the development of novel or improved antiviral strategies such as vaccines and
biomarkers for personalized medicine, ”omics tools” are used to study the induction and regulation
of the host (immune) response to viral infections. In a biomarker study, we investigated whether
there exists a blood genomic signature that can accurately predict the course of respiratory syncytial
virus (RSV) infection in young infants. RSV causes infections that range from the common cold to
severe lower respiratory tract infection requiring high-level medical care. The prediction of the course
of disease in individual patients is challenging at first visits to pediatric wards, as RSV infections
may rapidly progress to severe disease. We used early blood microarray transcriptome profiles
collected from 39 hospitalized infants (collected within 24 h of hospitalization) that were followed
until recovery and for whom the level of disease severity was determined retrospectively. Applying
support vector machine learning on age-by-sex standardized transcriptomic data, an 84-gene signature
was identified that discriminated hospitalized infants with eventually less severe RSV infection
from infants that suffered from the most severe RSV disease. This signature yielded an area under
the receiver operating characteristic curve (AUC) of 0.966 using leave-one-out cross-validation on
the experimental data and an AUC of 0.858 on an independent validation cohort consisting of 53
infants [22]. The presented signature may serve as the basis on which to develop a prognostic test
to support clinical management of RSV patients. Follow-up studies are, however, needed to assess
the pathogenic-specific—and/or disease-severity-specific—nature of the gene signature identified.
Genome-wide association studies may identify host genetic factors predisposing to severe disease, but
other approaches such as immune repertoire sequencing may help us to assess the contribution of
other (external) factors, such as, for example, infection history to the development of (severe) disease
upon infection. As a first step in this direction, we developed RTCR: a pipeline for complete and
accurate recovery of T-cell repertoires from high-throughput sequencing data. This pipeline supports
distinguishing between true but rare TCR sequences and variants generated by polymerase chain
reaction and sequencing errors. RTCR employs a data-driven statistical model to rectify PCR and
sequencing errors in an adaptive manner. Using simulations, we demonstrated that RTCR can easily
adapt to the error profiles of different types of sequencers and exhibits a consistently high recall and
high precision even at low coverages at which other pipelines perform poorly [23]. Using the RTCR
pipeline, we analyzed a longitudinal dataset obtained from a healthy donor. The results showed that a
healthy repertoire is highly dynamic: T-cell memory clone sizes appeared to undergo major shifts in
abundance, demonstrating that small snapshots of the full repertoire nevertheless contained a wealth
of information. Pattern analysis of paired (longitudinal) datasets will allow detailed studies of infection
and, for example, vaccination-induced host responses.
2.5. Dino McMahon Gave a Powerful Talk on Evolution, Virulence, and the Recombination of Emerging
Bee Viruses
Bee populations have declined significantly in recent years, and this is thought to be attributable at
least in part to the (re-)emergence of viruses. These viruses are predominantly positive single-stranded
(+ss) RNA viruses belonging to the Picornavirales. Managed honeybees are often infested with
the invasive mite, Varroa destructor, which vectors RNA viruses, including deformed wing virus
(DWV; family Iflaviridae), a leading culprit of colony losses. Many bee viruses have been sequenced,
and structural features are now available for viruses such as DWV. DWV consists of at least
three distinct genotypes, two of which have been shown to be differentially virulent in honeybees.
Molecular studies have demonstrated that DWV has a mean evolutionary rate of 1.35 × 10−3 per
site per year. For such viruses—in contrast with their eukaryotic hosts—ecological and evolutionary
timescales significantly overlap. This rapid evolution allows RNA viruses to adapt quickly to novel
host environments, with recombination representing an additional key source of genetic variation.
Interestingly, recombination between genotypes of DWV has recently been shown to be a common
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occurrence in honeybees. A challenge has been to develop bioinformatics tools that can accurately
reconstruct viral haplotypes—including recombinants—from heterogenous high-throughput sequence
data. The impact of blood-to-blood V. destructor transmission on virus evolution represents an
important question in bee virus research. Because of the nature of the V. destructor life cycle, predictions
can be made about the potential impact of the mite on virus virulence evolution. Specifically,
the developing honeybee host pupa should remain alive until close to the completion of metamorphosis
to provide sufficient time for successful mite reproduction, including offspring mating. For optimal
transmission, any virus found in a mature and mated daughter mite will hold a significant selective
advantage over a virus found in an immature or unmated daughter mite—placing a cost on virus
virulence that impacts honeybee pupae before mites can mate. On the other side, viruses replicating too
slowly and with delayed virulence effects will hold a selective handicap because fewer transmission
units will be found in mated mites. I have hypothesized that the evolution of virus virulence shifted
following the arrival of V. destructor, with viruses, including recombinants and/or specific viral
genotypes, being selected for a level of virulence in pupae (and likely also in adults) that maximizes
R0, which represents the basic reproductive number of the virus in the host population. R0 is defined
by the number of subsequent infections caused by a single infection, and it must be greater than 1 for
an infection to spread in a population. It is enhanced by maximizing the number of transmission units
passed to uninfected susceptible vectors and ultimately hosts (Figure 1).
Figure 1. Hypothetical impact of indirect vector transmission on virus virulence evolution in Apis
mellifera. The Varroa destructor reproductive life cycle is shown, with mites depicted at various
developmental stages. A mother mite lays maximally three eggs that can mature to adulthood before
hosts emerge from the brood cell. Virulence should evolve to an intermediate level that maximizes
transmission (white region). Too virulent (red region) and the virus will have suboptimal transmission
as a result of high host mortality preventing mite mating/host eclosion; not virulent enough (blue
region) and the virus will have suboptimal transmission as a result of low growth (fewer transmission
units). Reproduced with permission from McMahon, D.P.; Wilfert, L.; Paxton, R.J.; Brown, M.J.F.
Emerging viruses in bees: from molecules to ecology. Adv. Virus. Res. 2018, in press. (https://doi.org/
10.1016/bs.aivir.2018.02.008).
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Honeybee viruses are also shared with sympatric wild bees, and viral prevalence and sequence
data indicate frequent virus transmission between managed and wild-bee species. In addition to
infecting the western honeybee (Apis mellifera), DWV can infect other Asian honeybee species, such as
Apis ceranae. Aside from honeybees, DWV has been found widely in bumblebees, including solitary
bees, and in wasps, and there is evidence that it can actively replicate in several Bombus and solitary-bee
species. Whether the arrival of the V. destructor mite in A. mellifera has driven the viral emergence in
non-Apis bees is a target of ongoing research.
2.6. Arthur Gruber Talked about Rational Design of Profile HMMs for Viral Detection, Classification
and Discovery
Some of the most devastating pandemic diseases have arisen through the transmission of
emerging viruses that have not been identified before the tragic consequences of their dissemination.
The detection of novel viruses is a challenging task because of their high evolutionary rates, which
result in high sequence divergence. The development of new computational approaches is, therefore,
of utmost importance. Profile HMMs are a powerful way of modeling sequence diversity and
constitute a very sensitive approach to detecting emerging viruses [24]. Our group has recently
developed GenSeed-HMM [25], a tool that employs profile HMMs as seeds for progressive assembly,
using genomic and metagenomic data. Here we report the development and implementation of
TABAJARA (Figure 2), a tool for the rational design of profile HMMs. Starting from a multiple sequence
alignment (MSA), TABAJARA is able to find blocks that are either (1) conserved across all sequences or
(2) discriminative for two or more specific groups of sequences. The program uses different metrics
to ascribe position-specific scores along the whole alignment and then uses a sliding window to find
top-scoring regions. Selected alignment blocks are then extracted and used to build profile HMMs. To
validate such models, we used sequence data from phages of the Microviridae family and members of
the Flavivirus genus. In both viral groups, we were able to obtain wide-range seeds (generic for all
members of Microviridae or Flavivirus) and narrow-range seeds, exclusive to specific Microviridae
subfamilies (Alpavirinae and Gokushovirinae) or to particular Flavivirus species (e.g., DENV, ZIKV, or
YFV). Additionally, using TABAJARA’s generated profile HMMs as seeds, we succeeded to reconstruct
specific viral sequences with the GenSeed-HMM program using different metagenomic datasets. Finally,
we also report the development of e-Finder, a program that uses profile HMMs to identify clusters of
genes in a specified syntenic context. This tool allows the detection of viral and nonviral elements such
as prophages, transposons, CRISPR-Cas systems, and operons in assembled genomes. These programs
constitute a toolbox and can be used alone or in combination to detect and classify known viruses as
well as distantly related viruses that may represent potentially emerging pathogens. This work was
done by the team composed of Liliane S. Oliveira, Dolores U. Mehnert, Paolo M. A. Zanotto, Alan M.
Durham, Alejandro Reyes, and Arthur Gruber.
2.7. Richard Scheuermann Shared His Great Experience with Contemporary Circulating EV-D68 Strains
Showing Differential Viral Entry and Replication in Human Neuronal Cell Cultures
Historically, enterovirus D68 (EV-D68) has only been associated with respiratory illnesses.
However, in the summer of 2014, an EV-D68 outbreak coincided with a spike in polio-like acute
flaccid myelitis/paralysis (AFM) cases. Statistical analysis suggested that the number of AFM cases
was significantly higher during the EV-D68 outbreak than in historical controls. These reports have
raised concerns that the EV-D68 virus could have been the causative agent of AFM during this recent
outbreak. We recently reported a phylogenetic analysis of the 2014 outbreak and found that isolates
associated with AFM belonged to a single phylogenetic subclade, B1 [26]. To determine if specific
EV-D68 genetic determinants are associated with neuropathogenesis, we used a neuroblastoma-derived
neuronal cell line, SH-SY5Y, as a cell culture model to explore the differential infection permissibility
for different EV-D68 strains. In contrast to HeLa and A549 cells, which support viral infection of
all EV-D68 strains tested, SH-SY5Y cells only support infection of a subset of contemporary EV-D68
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strains, including MO/14-18947 and MO/14-18949, members of the B1 subclade from the 2014 outbreak.
Viral replication and infectivity in SH-SY5Y was assessed using four independent assays—infectious
virus production, cytopathic effects, cell viability assay, and VP1 capsid protein production. Similar
differential neurotropisms were observed in a paralytic mouse model. In addition to supporting virus
replication and other functional studies, this cell culture model may help to confirm epidemiological
associations between EV-D68 strains and AFM and allow for the rapid identification of emerging
neurotropic strains of EV-D68.
Figure 2. Workflow of TABAJARA program.
This work was done by David M. Brown, Lauren M. Oldfield, Alison M. Hixon, Yun Zhang, Mark
Novotny, Wei Wang, Suman Das, Reed S. Shabman, Kenneth Tyler, and Richard H. Scheuermann.
The study is funded by the National Institute of Allergy and Infectious Diseases (NIH/DHHS) under
Contract No. HHSN272201200005C.
2.8. Alexandra Zhernakova Presented Virome Analysis Using Metagenomics Sequencing Data from Population
and Patient Cohorts
The human gut microbiome contains millions of viruses, bacteria, protozoa, and fungi. The
abundance of bacterial species and the diversity of bacterial compositions have now been linked to
many host diseases and conditions, in particular, to predispositions to autoimmune diseases, metabolic
conditions, obesity, and cancer. Although the bacterial part of the human microbiome has been
relatively well studied, the virome contribution remains largely unexplored, despite gut viruses
forming a substantial part of the total microbiome: the proportion of viruses in adults is estimated to be
5–10% of the number of bacteria. Several pioneering studies have indicated that viruses are relatively
stable in time and are associated with gut diseases, particularly with inflammatory bowel disease.
Virome-specific isolation of nucleic acids from stool samples requires additional, currently laborious,
methods. However, given the high abundance of viruses in the gut, metagenomic sequencing of all
DNA isolated from stool should contain a substantial proportion of viral DNA. In this work, we aimed
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to investigate the gut virome abundance in a population cohort, Lifelines-DEEP (1179 samples), and
compared it that of with patients suffering from inflammatory bowel disease (n = 355) and irritable
bowel syndrome (n = 400). We tested three tools commonly used for the analysis of gut metagenomics
data: (1) MetaPhlAn; (2) Kraken; and (3) DUDes. All three tools detected viruses in only a minority of
the Lifelines-DEEP samples (25% in MetaPhlAn, 27% in Kraken, and 8% in DUDes), with moderate
overlap across the three methods (Figure 3). The tools also indicated a low overall abundance of
viruses (<1%) and a moderate overlap in taxa detected across virome-positive samples. The proportion
of identified viruses did not correlate with the read depth of metagenomic sequencing. The most
abundant viral family detected by all three methods was Siphoviridae, double-stranded DNA viruses
that infect bacteria and archaea. This family contains several bacteriophages specific for Lactococcus
and Leuconostock bacteria, and, consistently with this, we also observed a positive correlation of
Siphoviridae viruses with the abundance of these bacteria and with the intake of milk products. We
further observed an increased proportion of viral species in individuals with inflammatory bowel
disease and irritable bowel syndrome. Overall, our virome analysis using existing metagenomics tools
yielded unexpectedly low proportions of viruses in the stool samples of healthy individuals, and we
saw remarkable differences in the results of the different tools. It is likely that virome reads remain
in the unannotated fraction of the metagenomics data, which is substantial in all three methods (at
least 30%). Other virome-specific tools and de novo data assembly methods are therefore required
to determine the true viral proportion and abundance in metagenomics data. Data analysis for this
project was performed by Sanzhima Garmaeva, PhD student in the Department of Genetics, UMCG.
Figure 3. Number of shared samples with detected viruses (k_Viruses) in all three methods.
2.9. François Enault Introduced the Study of Viral Communities Using Metagenomics
Although viruses are considered as major players in natural ecosystems, their comprehensive
study has been hampered by the necessity of isolating and cultivating their host and by the absence
of a single gene common to all viral genomes. Viral metagenomics, based on culture-independent
sequencing, is a well-fitted approach to provide insights into the composition, structure, and dynamics
of environmental viral communities. However, specific computational methods are required to analyze
these viral metagenomes (or viromes). First, we developed a method to estimate the proportion of cellular
sequences in viromes. A quarter of the published datasets were found to contain a substantial number of
sequences originating from cellular genomes, either as a result of shortcomings in experimental protocols,
as virus-like particles (VLPs) are described as difficult to purify from some matrices (soil, sediments,
and animal-associated samples), or because of VLPs containing cellular DNA (membrane vesicles, gene
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transfer agents, or due to phage transduction). When considering viromes with no cellular DNA detected,
a significant number of cellular metabolism genes were retrieved, for example, some ribosomal proteins,
suggesting that the presence of auxiliary genes involved in various metabolic pathways within viral
genomes is a general trend in the virosphere [27]. We then applied this method to quantify the presence
of cellular DNA in gut viromes, as recent virome analyses suggest that antibiotic resistance genes (ARGs)
are frequently carried by phages, which is inconsistent with the traditional view that phage genomes
rarely encode ARGs but contribute to their spread through horizontal transfer mediated by generalized
transduction. The reanalysis of available human- or mouse-associated gut viromes for ARGs and their
genomic context suggested that ARGs are rarely encoded in phage genomes but more likely originate
from phage particles containing bacterial DNA [28].
Considering the fact that viromes can contain a substantial number of sequences originating
from cellular genomes, a tool was developed to identify viral sequences in such datasets. Using
both homology to reference viral sequences and viral genome characteristics, VirSorter complements
existing prophage prediction software and was proved to be able to identify viral signals in assembled
sequence (contigs) as short as 3 kb [29].
Once the viral contigs are identified, determining the identity of their hosts is crucial for
deciphering the interactions and dynamics between microbes and their viruses and thus for our
ecological understanding of the microbiome. To determine the hosts of the newly sequenced viruses,
we used the fact that viruses tend to have a genomic signature similar to their prokaryotic hosts. Using
homogeneous Markov models, our tool WisH was found to predict hosts for short phage genomic
fragments with a better accuracy than existing tools such as VirHostMatcher [30]. Furthermore, WisH
runs several hundred times faster than this software and scales up to large datasets [31].
Using bioinformatic methods and software, we studied viral communities in aquatic systems
such as freshwater lakes and hypersalin ponds, and in the context of the Virus-X EU project (Horizon
2020 Project No. 685778), we mostly focused on Icelandic hot springs. The analysis of viromes informs
us about the composition, diversity, and dynamics of the viral communities in these environments
and allowed us to analyze the main viral families retrieved in these datasets, mostly Caudovirales and
ssDNA viruses such as Microviridae.
This work was done by Simon Roux, Clovis Galiez, Jonathan Vincent, Marie-Agnès Petit, Matthew
B. Sullivan, Johannes Söding, Didier Debroas, Mart Krupovic, and François Enault.
2.10. Brett Pickett Discussed Genome Sequencing and Serodiagnostics for Zika Virus
Zika virus (ZIKV) is responsible for an ongoing outbreak concentrated in South and Central
America and the Caribbean, with travel-based cases being reported around the globe. In addition, new
outbreak clusters located in the southeastern United States have been attributed to autochthonous
transmission. As multi-disciplinary collaborations are forming to combat the ZIKV outbreak, it
is imperative to authenticate and sequence-verify existing reagents prior to performing infection
experiments to better understand and combat increasing virulence. Here, we report high-quality
sequence data for multiple ZIKV strains available from the Biodefense and Emerging Infections
Research Resources Repository (BEI Resources). These sequence data include the historical reference
strain from the African lineage (MR-766), the Asian lineage derived American reference strain
(PRVABC59), and several other strains collected from around the world during the 2015 outbreak
with documented passage histories. We used next-generation sequencing coupled with 3’ rapid
amplification of cDNA ends (RACE) and viral genome annotation pipelines to generate consensus
sequence records in GenBank. We applied a deep-sequencing analysis method to identify minor
variants, which exist as natural quasi-species within viral stocks. We detected minor variants that
consistently resulted in nonsynonymous substitutions at multiple codons among a subset of the Asian
strains. Interestingly, the nonstructural protein 1 (NS1) and membrane glycoprotein (prM) coding
regions had the highest number of minor variants in the Asian and African lineages, respectively.
The evolutionary relationships for these strains were determined using phylogenetic methods, and a
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single recombinant sequence was identified. These bioinformatics analyses of the sequencing results
confirm that the BEI Resources virus stocks available to the scientific research community adequately
represent the viral population diversity of ZIKV and justify additional wet-lab experiments. In
addition, we used peptide arrays consisting of 866 15-mer peptides (in quadruplicate) to screen 140
well-characterized human convalescent sera for peptides that differentiate between past infection
with multiple mosquito-borne viruses. Peptides representing dengue virus serotypes 1–4 and West
Nile, Chikungunya, and Zika viruses were synthesized chemically and linked covalently to glass
slides prior to measuring peptide-specific binding of anti-virus IgG for these seven mosquito-borne
viruses. The data from all arrays were combined prior to applying multiple rounds of machine learning,
a weighting scheme, and a B-cell epitope prediction algorithm. Together, this novel computational
workflow identified pools of 10 immunodominant 15-mer peptides for each of the viruses. An indirect
ELISA protocol was optimized to enable the validation of our selected 15-mer peptides against large
collections of clinical serum samples. These experiments will enable the quantification of the diversity
in antibody responses against mosquito-borne viruses in human patients and can be used to enhance
vaccine development efforts, improve point-of-care diagnostics, and enable more accurate calculation
of seroprevalence in endemic areas.
2.11. Alice McHardy Presented the Prediction of the Evolution of Human Influenza A Viruses
Human influenza viruses cause short-term respiratory infections with considerable morbidity
and mortality in seasonal epidemics. A trivalent or quadrivalent vaccine protects against the two
circulating subtypes of influenza A (pH1N1 and H3N2) and against one or two lineages of influenza B
viruses. Because of the rapid antigenic evolution of the surface proteins, primarily the hemagglutinin,
the vaccine requires regular updates to remain effective. The World Health Organization (WHO)
maintains a global surveillance system and collects and analyzes data biannually to recommend strains
included in the vaccine for the next influenza seasons. Because of the lengthy vaccine production
process, this update has to be performed one year in advance. This is the “vaccine strain prediction
problem”, in which predicting a strain representing the predominant antigenic virus type has to be
made one year ahead of time. A false or late prediction results in vaccines with suboptimal protection
and an increase in influenza-related cases and mortality [32].
Over the last 10 years, we have worked on computational methods for predicting a necessary
vaccine strain, because of the emergence of a novel antigenic type, and investigated which strains could
be used for this update. In [33], we describe allele-dynamics plots, which rank alleles, corresponding to
sets of amino acid changes, in descending order by their increase in frequency over consecutive seasons.
In a constantly sized, homogenous population, this, with some statistical variance, relates directly to
the strength of the selective advantage that they may provide; “they may” because they may also all be
neutral. An allele is defined as the set of changes on an individual branch within a genealogy, which
allows for consideration of the genetic context of individual changes and for distinguishing between
events when individual changes are introduced multiple times. This method accurately ranked the
alleles with amino acid changes of HA corresponding to the changes between successive antigenic
types of influenza A/H3N2 viruses over the analyzed time period. Thus in practice, it appears that the
antigenic evolution of human influenza A viruses, likely as a result of the rapid global movements of
their human hosts, may be represented by such a simple population genetics model.
AD-plots, however, do not give us information about the antigenicity-altering nature of the
respective alleles; thus they do not directly point to antigenically altered alleles rising to predominance.
We thus devised antigenic trees, or more generally, phenotype trees [34], a method for regressing
antigenic distance measurements between viruses onto a tree. This allowed us to estimate the
antigenicity-altering effect of alleles and, from that, of individual sites or amino acid changes,
in agreement with experimental studies. Putting together AD-plots and antigenic trees allowed
for predicting suitable vaccine strains with improved performance in retrospective testing, namely, in
several cases one season earlier than the WHO [35].
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Differently from HA sequence data, which is made public in a timely manner [36], only little
antigenic data is released, which prevents providing predictions with this vaccine strain prediction
procedure in practice. We thus investigated whether we could identify some general characteristics
of the antigenic evolution of influenza A/H3N2 viruses that would be helpful for predicting vaccine
strain updates. To this end, we derived antigenicity-altering values per site from the antigenic-allele
information and used a graph-cut algorithm for finding antigenicity-altering sites on the HA structure
that cluster together, resulting in six patches of sites identified for HA [37]. This removed several
spurious antigenicity-altering sites reported with the antigenic tree because of co-localization on a
branch with a truly antigenicity-altering site. Of the six patches, patches 1 and 2 surrounded the
receptor binding site of HA. Almost all transitions between consecutive antigenic variants for H3N2
viruses included a change in either one or the other, as well as for time periods following the time
period covered by the antigenic data used for inference.
We added a statistical significance measure to the AD-plots for identifying alleles—now
corresponding to individual amino acid changes on a specific branch—rising to predominance. These
“sweep dynamics” (SD) plots indicate alleles increasing significantly in frequency over consecutive
seasons and with abundances above 50%—thus “sweeping” towards predominance. This, together
with antigenic patch information, provided the basis for a computational vaccine strain prediction
procedure (Figure 4). We observed good performance and earlier detection of novel emerging antigenic
variants, without analyzing antigenic data from after 2003 [38]. Since September 2017, we have
provided predictions simultaneously to the WHO (Figure 4). Currently, this method predicts a
necessary update of the H3N2 vaccine strain with a member of the 3C.2a2 clade, while the WHO
has not (yet) recommended this change. In several years, a performance comparison under realistic
circumstances will be possible. This work was done by Alice C. McHardy, Lars Steinbrück, Christina
Kratsch, Thorsten Klingen, and Susanne Reimering.
2.12. Mark Zwart Talked about Evolutionary Perspectives on the Role of Copy Number Variation in Viral and
Bacterial Adaptation
In many organisms, multiple copies of parts of the genome can be present, and the number of
copies present can vary within populations. We refer to such genomic diversity as copy number
variation (CNV). In bacteria, CNV plays an important role in adaptation, for example, in the presence
of antibiotics. Although the beneficial effects of CNV are often small, the mutation supply for CNV
is very large. Given the amount of standing genetic variation present in most bacterial populations,
selection can immediately act on CNV. CNV is therefore typically the first line of bacterial genetic
adaptation and is often followed later by single-nucleotide variants with greater beneficial effects and
a reversion of CNV. Although CNV plays an important role in bacterial adaptation, we know very
little about the role of CNV in virus adaptation. Virus genomes tend to be highly streamlined: any
inserted sequences—whether duplications of virus genes or heterologous genes—typically are rapidly
purged. One might therefore expect that CNV does not play a role in virus adaptation, but surprisingly
there are examples to the contrary. CNV is known to play a transient role in poxvirus adaptation to
new hosts: influenza A virus can downregulate the frequency of the genome segment coding for its
neuraminidase, and baculoviruses can regulate expression of infectivity factors through polymorphic
genomic deletions. Multipartite (or multi-component) viruses take a more radical approach and
package their different genome segments into different virus particles. At least one virus particle
containing each genome segment must then reach a new cell for the virus to be successfully transmitted.
This strange genome and virus particle organization comes at a huge cost: a predicted inefficient
transmission of the virus, both within and between hosts. Why has strange genome organization arisen?
Here, we explored this issue for a tripartite plant RNA virus, alfalfa mosaic virus. First, we revisited
classical virological work and considered infection kinetics in detail, documenting that multipartition
does indeed impose a huge cost on virus infectivity. Second, we found that the different genome
segments are not present at the same frequency, similar to observations with nanoviruses. When
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perturbed, the frequency of these segments converges to a stable equilibrium, which is host-species
dependent. These observations suggest that changes in the frequency of genome segments might
be a strategy for adapting to different environments, for example, because they lead to differences
in the expression of viral genes. Third, models of virus evolution show the importance of genetic
bottlenecks for adaptation by changes in the frequency of genome segments. These bottlenecks
generate the variation in segment frequencies on which selection can then act, which allows for rapid,
“mutation-free” adaptation to different environments. Finally, we used these models of virus evolution
to consider how heterogeneous environments must be to favor a multipartite over a monopartite
genome organization. Changes in genome segment frequencies might therefore play a similar role to
CNV in other viruses and bacteria, although the lack of linkage between these copies imposes both
unique costs to infectivity and a very large, continuous supply of variation for natural selection to
act on. These results stress that CNV can sometimes play an important role in virus adaptation and
suggests that it be given due consideration when considering high-throughput sequencing data.
Figure 4. Comparison of predominant antigenic types for human influenza A/H3N2, predictions
using sweep dynamics (SD) plots and recommendations made by the World Health Organization
(WHO). The selection of a vaccine strain takes place two seasons before the vaccine is available. Any
prediction of newly arising antigenically novel strains should therefore be compared to the predominant
antigenic type two seasons later (indicated by diagonal lines in plot). (First row) Colored boxes indicate
the predominant antigenic variant, and additional colored borders indicate different dominantly
circulating strains matching the same antigenic variant; (Second row) For the SD plots’ analysis,
seasons are marked with an “X” if sweep-related changes distinguish the WHO-selected vaccine strain
from the previous strain. Seasons with sweep changes not associated with antigenicity-altering or
avidity-changing sites are marked in grey; (Third row) Sweep-related changes in antigenicity-altering
or avidity-changing sites. Using these as a criterion for vaccine strain updates results in a simultaneous
or earlier detection of newly emerging antigenic types than with the procedure utilized by the WHO;
(Fourth row) Detected sweep-related sites known to change neither the avidity nor the antigenicity;
(Fifth row) WHO recommendations. Until 2017N, performance was evaluated by retrospective testing,
in which data from after the time of the WHO vaccine strain meeting for a particular season was
excluded from the analysis. From 2017S onwards, predictions were made for the future and can be
monitored live at https://github.com/hzi-bifo/SDplots_VaccineUpdates.
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2.13. Susana Posada Céspedes Spoke on the Bioinformatics Pipeline V-pipe for Inferring Viral Diversity from
High-Throughput Sequencing Data
RNA viruses are responsible for various infectious diseases in humans, animals, and crops,
representing a burden to human health as well as causing substantial economic losses. One major
limitation when treating viral infections is the great genetic diversity featured by RNA viruses.
The existence of a heterogeneous mixture of viral strains has implications on viral pathogenesis,
virulence, and disease progression. HTS technologies have opened up new possibilities for in-depth
characterization of the diversity of viral samples, and the ultimate goal is to define standards for
research as well as to incorporate the use of this technology into clinical diagnosis. In order to
support HTS-based viral genomics, we devised and implemented a bioinformatics pipeline, V-pipe.
The workflow integrates tools for the assessment of the viral diversity at the levels of both single
nucleotide variants (SNVs) and viral haplotypes. V-pipe is an automated and easy-to-use framework
delivering reproducible results. Furthermore, it features a modular and extensible architecture that
enables developers to easily test their own tools, contributing towards the establishment of best
practices for clinical diagnostics. This work was done by Susana Posada-Céspedes, David Seifert,
Tobias Marschall, and Niko Beerenwinkel.
2.14. Philippe Lemey Described Bayesian Phylogenetic and Phylodynamic Data Integration Using BEAST
The field of phylodynamics has witnessed a rich development of statistical inference tools with
increasing levels of sophistication, but these tools have traditionally focused on sequences as their sole
data source. Integrating various sources of information with genomic data promises to deliver more
precise insights into infectious diseases and to increase opportunities for statistical hypothesis testing.
Emerging concepts of data integration are now stimulating new advances in Bayesian evolutionary
inference methodology. We have worked on such methodology in the BEAST software, which
represents a coherent statistical framework for integrated analyses of sequences and traits using
Bayesian inference techniques. These approaches were applied in various outbreak scenarios and
real-time genomic epidemiology. For discrete traits, we have developed generalized linear modeling
extensions of continuous-time Markov chain processes that allow the integrating and testing of
covariates. Applications using this approach have focused on the dynamics of spatial spread for viruses
such as influenza and Ebola. We have also developed equivalent random walk models for continuous
traits to test specific hypotheses about the impact of border closures on Ebola dispersal frequency. The
2013–2016 West African Ebola epidemic marked the start of real-time genomic sequencing, and this
methodology can make an important impact on outbreak responses. Recent work during the Lassa
fever virus outbreak demonstrated this and brings about new bioinformatics challenges.
3. Poster Sessions
One important facet of the annual EVBC meeting was the poster sessions. The friendly atmosphere
was instrumental to developing fruitful discussions during the long poster sessions combined with
lunches and dinners.
4. Conclusions
The second EVBC meeting was a success in its primary aims of bringing virologists and
bioinformaticians together to share ideas, agree on differences of opinion, and create a future
action agenda.
Collectively, this meeting hosted 15 oral presentations and 2 long poster sessions over a two day
period with around 120 participants. This report presents an overview of salient new developments
and novel research findings that emerged during the second EVBC annual meeting. We hope that the
highlights provided in this report will encourage interested researchers to join us at the Third Annual
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Meeting of the European Virus Bioinformatics Center, which will be held in 2019 at the University of
Glasgow; wish to see you all again.
5. Affiliations of Attendees
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Akbar Adjie Pratama University of Groningen Groningen-Netherlands
Alessandro Rossi Utrecht University Utrecht-Netherlands
Alexander Schoenhuth Centrum Wiskunde & Informatica Amsterdam-Netherlands
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Alexandra Belanova Free University of Berlin Berlin-Germany
Alexandra Zhernakova University Medical Centre Groninge Groningen-Netherlands
Ali Elbehery Helmholtz Center Munich Munich-Germany
Alice Fusaro Istituto Zooprofilattico Sperimentale
delle Venezie
Legnaro-Italy
Alice McHardy Helmholtz Center for Infection
Research
Braunschweig-Germany
Ana Rita Costa Delft University of Technology Delft-Netherlands
Anita Schurch University Medical Center Utrecht Utrecht-Netherlands
Anne Kupczok Kiel University Kiel-Germany
Annelies Kroneman Netherlands National Institute for
Public Health and the Environment
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Arno C. Andeweg Erasmus Medical Center Rotterdam-Netherlands
Arthur Gruber University of São Paulo São Paulo-Brazil
Arthur Edridge University of Amsterdam Amsterdam-Netherlands
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Bas Oude Munnink Erasmus University Medical Center Rotterdam-Netherlands
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Bashar Ibrahim Friedrich Schiller University Jena Jena-Germany
Bastiaan Von Meijenfeldt University of Utrecht Utrecht-Netherlands
Ben Stamp MRC-University of Glasgow Centre for
Virus Research
Glasgow-Scotland
Brett Pickett J. Craig Venter Institute Rockville-USA
Ceren Simsek Katholieke Universiteit Leuven Leuven-Belgium
Cesare Gruber National Institute for Infectious
Diseases
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Chenyan Shi Katholieke Universiteit Leuven Leuven-Belgium
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Virus Research
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David Nieuwenhuijse Erasmus University Medical Center Rotterdam-Netherlands
Daniel Desiro Friedrich Schiller University Jena Jena-Germany
Dennis Schmitz Netherlands National Institute for
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Erik De Vries Utrecht University Utrecht-Netherlands
Eric Hester Radboud University Nijmegen-Netherlands
Eugene Koonin National Center for Biotechnology
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Virus Research
Glasgow-UK
François Enault Université Clermont Auvergne Clermont Ferrand-France
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Franklin Nobrega Delft University of Technology Delft-Netherlands
Gianpiero Zamperin Istituto Zooprofilattico Sperimentale
delle Venezie
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Research
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Guillaume Beauclair InstitutPasteur Paris-France
Harry Vennema Netherlands National Institute for
Public Health and the Environment
Bilthoven-Netherlands
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Kathrin Trappe Robert Koch-Institute Berlin-Germany
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Kim Ng Statens Serum Institute Copenhagen-Denmark
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